TXTM insider trading
OTC Markets OTCPK HealthcareProText Mobility, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About ProText Mobility, Inc.
ProText Mobility, Inc., a biotech company, engages in the development of pharmaceutical botanical medicines. Its medicines are formulated with highly-bioavailable plant extracts. The company is based in Fort Lauderdale, Florida.
Company website: www.protxtm.com
TXTM insider activity at a glance
FilingIQ has scored 11 insider transactions for TXTM since Jun 3, 2022. The most recent filing in our index is dated Apr 7, 2026.
Across the full history, 3 open-market purchases
and 0 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on TXTM insider trades is 74.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest TXTM Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for TXTM?
- FilingIQ tracks 11 Form 4 insider transactions for TXTM (ProText Mobility, Inc.), covering filings from Jun 3, 2022 onwards. 1 of those were filed in the last 90 days.
- Are TXTM insiders net buyers or net sellers?
- Across the full Form 4 history for TXTM, 3 transactions (27%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does TXTM insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is TXTM in?
- ProText Mobility, Inc. (TXTM) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $54.95M.
Methodology & sources
Every TXTM insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.